Comparison of volumetric capillary cytometry with standard flow cytometry for routine enumeration of CD34+ cells

Transfusion

Volumn 39, Issue 8, 1999, Pages 864-872

  Cabezudo, Elena ^a   Querol, S ^a   Cancelas, J A ^a   Garcia J ^a  

^a Institut de Recerca Oncologica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN;

APHERESIS; ARTICLE; AUTOMATION; CELL COUNT; CLONOGENIC ASSAY; COLONY FORMING UNIT; FLOW CYTOMETRY; REGRESSION ANALYSIS; REPRODUCIBILITY; STEM CELL; UMBILICAL CORD BLOOD; VOLUMETRY;

ANTIGENS, CD34; BLOOD; BLOOD CELL COUNT; COLONY-FORMING UNITS ASSAY; CYTOLOGICAL TECHNIQUES; FEASIBILITY STUDIES; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LINEAR MODELS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0033360883     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39080864.x     Document Type: Article

References (45)

1. Siena S, Bregni M, Brando B, et al. Flow cytometry for the clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-9.
2. Sutherland DR, Keating A. The CD34 antigen: structure, biology, and potential clinical applications. J Hematother 1992;1:115-29.
3. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
4. Siena S, Bregni M, Brando B, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intra-venous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989;74:1905-14.
5. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-41.
6. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
7. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
8. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
9. Sandhaus LM, Edinger MG, Tubbs RR, et al. A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment. Exp Hematol 1998;26:73-8
10. Armitage S, Hargreaves R, Samson D, et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587-91.
11. Chapple P, Prince HM, Quinn M, et al. Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant 1998;22:125-30.
12. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14:970-3.
13. Remes K, Matinlauri I, Grenman S, et al. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. J Hematother 1997;6:13-9.
14. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
15. Wagner JE, DeFor T, Rubinstein P, Kurtzberg J. Transplantation of unrelated donor umbilical cord blood: outcomes and analysis of risk factors (abstract). Blood 1997;90(Suppl 1):1767A.
16. Lowdell MW, Bainbridge DR. External quality assurance for CD34 cell enumeration - results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes. Bone Marrow Transplant 1996; 17:849-53.
17. Gratama JW, Kraan J, Levering W, et al. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 1997;30:109-17.
18. Chin-Yee I, Anderson L, Keeney M, Sutherland DR. Quality assurance of stem cell enumeration by flow cytometry. Canadian QASE Study Group. Cytometry 1997;30:296-303.
19. Beveridge R, Geller RB, Giguere J, et al. CD34 enumeration in a multicenter study. The AOR Stem Cell Group. J Hematother 1997;6:285-6.
20. Johnsen HE. Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995;4:21-8.
21. Wunder E, Sovalat H, Fritsch G, et al. Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization - Mulhouse, France, February 6-8 and 14-15, 1992. J Hematother 1992;1:131-42.
22. Johnsen HE, Knudsen LM. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the Second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G). J Hematother 1996;5:237-45.
23. Chang A, Ma DD. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group. J Hematother 1996;5:605-16.
24. Marti G, Johnsen H, Sutherland R, Serke S. A convergence of methods for a worldwide standard for CD34+ cell enumeration (letter). J Hematother 1998;7:105-9.
25. Johnsen HE. Toward a worldwide standard for CD34+ enumeration? (letter). J Hematother 1997;6:83-9.
26. Sutherland DR, Anderson L, Keeney M, et al. Re: toward a worldwide standard for CD34+ enumeration (letter). J Hematother 1997;6:85-9.
27. Dietz LJ, Dubrow RS, Manian BS, Sizto NL. Volumetric capillary cytometry: a new method for absolute cell enumeration. Cytometry 1996;23:177-86.
28. O'Gorman MR, Gelman R. Inter- and intrainstitutional evaluation of automated volumetric capillary cytometry for the quantitation of CD4- and CD8-positive T lymphocytes in the peripheral blood of persons infected with human immunodeficiency virus. Site Investigators and the NIAID New CD4 Technologies Focus Group. Clin Diagn Lab Immunol 1997;4:173-9.
29. Adams MR, Johnson DK, Busch MP, et al. Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis products. Transfusion 1997;37:29-37.
30. Sims LC, Brecher ME, Gertis K, et al. Enumeration of CD34-positive stem cells: evaluation and comparison of three methods. J Hematother 1997;6:213-26.
31. Read EJ, Kunitake ST, Carter CS, et al. Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry. J Hematother 1997;6:291-301.
32. Sutherland DR, Keating A, Nayar R, et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-10.
33. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-26.
34. Schmid I, Krall WJ, Uittenbogaart CH, et al. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992;13:204-8.
35. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998;34:61-70.
36. Martin-Henao GA, Ingles-Esteve J, Cancelas JA, Garcia J. Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS). Bone Marrow Transplant 1996;18:603-9.
37. Trischmann TM, Schepers KG, Civin CI. Measurement of CD34+ cells in bone marrow by flow cytometry. J Hematother 1993;3:305-13.
38. Evans RD. The atomic nucleus. New York: McGraw-Hill, 1955.
39. Barnett D, Granger V, Storie I, et al. Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol 1998;103:553-65.
40. Parley TJ, Rooney W, Kuhns E, et al. An intralaboratory quality control program for quantitation of CD34+ cells by flow cytometry. J Hematother 1997;6:303-8.
41. Leibundgut K, Von Rohr A, Brulhart K, et al. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995;15:25-31.
42. Humpe A, Riggert J, Vehmeyer K, et al. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997;37:1050-7.
43. Homburger H, Rosenstock W, Paxton H, et al. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey. Ann N Y Acad Sci 1993;677:43-9.
44. Simson E, Groner W. Variability in absolute lymphocyte counts obtained by automated cell counters. Cytometry 1995;22:26-34.
45. Lee LG, Head DF, Dubrow RS, Baer TM. Near-IR dyes in three color volumetric capillary cytometry: cell analysis with 633 and 785 nm laser excitation. Cytometry 1995;21:120-8.